- Home
- TRMB vs BMRN Comparison
TRMB vs BMRN Comparison
Compare TRMB & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMB
- BMRN
- Stock Information
- Founded
- TRMB 1978
- BMRN 1996
- Country
- TRMB United States
- BMRN United States
- Employees
- TRMB N/A
- BMRN N/A
- Industry
- TRMB Industrial Machinery/Components
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- TRMB Industrials
- BMRN Health Care
- Exchange
- TRMB Nasdaq
- BMRN Nasdaq
- Market Cap
- TRMB 15.1B
- BMRN 12.1B
- IPO Year
- TRMB 1990
- BMRN 1999
- Fundamental
- Price
- TRMB $71.27
- BMRN $58.07
- Analyst Decision
- TRMB Buy
- BMRN Buy
- Analyst Count
- TRMB 5
- BMRN 22
- Target Price
- TRMB $87.40
- BMRN $93.43
- AVG Volume (30 Days)
- TRMB 1.4M
- BMRN 2.2M
- Earning Date
- TRMB 05-07-2025
- BMRN 05-01-2025
- Dividend Yield
- TRMB N/A
- BMRN N/A
- EPS Growth
- TRMB 538.84
- BMRN 152.82
- EPS
- TRMB 6.14
- BMRN 2.71
- Revenue
- TRMB $3,570,600,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- TRMB N/A
- BMRN $12.27
- Revenue Next Year
- TRMB $7.52
- BMRN $10.08
- P/E Ratio
- TRMB $11.61
- BMRN $21.47
- Revenue Growth
- TRMB N/A
- BMRN 19.36
- 52 Week Low
- TRMB $48.65
- BMRN $52.93
- 52 Week High
- TRMB $77.78
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- TRMB 62.87
- BMRN 41.32
- Support Level
- TRMB $69.33
- BMRN $57.27
- Resistance Level
- TRMB $72.22
- BMRN $59.12
- Average True Range (ATR)
- TRMB 1.17
- BMRN 1.40
- MACD
- TRMB -0.05
- BMRN 0.06
- Stochastic Oscillator
- TRMB 63.40
- BMRN 18.34
About TRMB Trimble Inc.
Trimble Inc provides a technology solutions provider that enables office and mobile professionals to connect their workflows and asset lifecycles to drive a more productive, sustainable future. The company has four reportable segments: Buildings and Infrastructure, Geospatial, Resources and Utilities, and Transportation. The company generates the majority of its revenue from the Buildings and Infrastructure segment, which primarily serves customers working in architecture, engineering, construction, design, asset management, operations, and maintenance.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.